Insiders / Orbimed Advisors LLC
Orbimed Advisors LLC
CIK 1055951personinsiderfundbeneficial owner
Companies
8
First seen
Jan 27, 2026
Last activity
Jun 24, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Enliven Therapeutics, Inc. · ELVN | 6,555,102 | — |
| Sionna Therapeutics, Inc. · SION | 5,343,543 | — |
| Traws Pharma, Inc. · TRAW | 1,203,250 | — |
| Prelude Therapeutics Incorporated · PRLD | 1,126,126 | — |
| Q32 Bio Inc. · QTTB | 625,000 | — |
| Adicet Bio, Inc. · ACET | 0 | — |
| ImageneBio, Inc. · IMA | — | — |
| Shattuck Labs, Inc. · STTK | — | — |
All securities held
10 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Enliven Therapeutics, Inc. | Common Stock | 6,555,102 |
| ImageneBio, Inc. | Pre-Funded Warrants (right to buy)Derivative | 384,689 |
| Prelude Therapeutics Incorporated | Common Stock | 1,126,126 |
| Q32 Bio Inc. | Common Stock | 625,000 |
| Shattuck Labs, Inc. | Pre-Funded Warrants (right to buy)Derivative | 5,303,908 |
| Sionna Therapeutics, Inc. | Common Stock | 5,343,543 |
| Traws Pharma, Inc. | Common Stock | 1,203,250 |
| Traws Pharma, Inc. | Series C Warrants (right to buy)Derivative | 1,793,187 |
| Traws Pharma, Inc. | Series A Warrants (right to buy)Derivative | 597,729 |
| Traws Pharma, Inc. | Series B Warrants (right to buy)Derivative | 597,729 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $35.72M | -787K -10.65% | 6,601,878 9.01% of shares | high |
| Jun 15, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $12.26M | -272K -3.55% | 7,388,902 10.08% of shares | high |
| Apr 15, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $10.53M | -236K -6.77% | 3,247,025 7.18% of shares | medium |
| Apr 16, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $10.29M | -227K -6.99% | 3,020,119 6.68% of shares | medium |
| May 28, 2026 | Buy | QTTB Q32 Bio Inc. Common Stock | $10.00M | +1.3M +55.48% | 3,502,987 11.77% of shares | high |
| May 11, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $8.53M | -185K -6.46% | 2,671,822 5.91% of shares | medium |
| Apr 21, 2026 | Buy | PRLD Prelude Therapeutics Incorporated Common Stock | $7.50M | +1.7M +16.69% | 11,808,945 14.80% of shares | high |
| May 28, 2026 | Buy | QTTB Q32 Bio Inc. Common Stock | $5.00M | +625K | 625,000 2.10% of shares | high |
| Apr 21, 2026 | Buy | PRLD Prelude Therapeutics Incorporated Common Stock | $5.00M | +1.1M | 1,126,126 1.41% of shares | high |
| May 8, 2026 | Sell | SION Sionna Therapeutics, Inc. Common Stock | $2.66M | -60K -2.05% | 2,856,461 6.32% of shares | medium |